Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherAccelerated Communication

Molecular Determinants of Proton-Sensitive N-Methyl-d-aspartate Receptor Gating

Chian-Ming Low, Polina Lyuboslavsky, Adam French, Phuong Le, Karen Wyatte, William H. Thiel, Edward M. Marchan, Kazuei Igarashi, Keiko Kashiwagi, Kim Gernert, Keith Williams, Stephen F. Traynelis and Fang Zheng
Molecular Pharmacology June 2003, 63 (6) 1212-1222; DOI: https://doi.org/10.1124/mol.63.6.1212
Chian-Ming Low
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polina Lyuboslavsky
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam French
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phuong Le
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Wyatte
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William H. Thiel
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward M. Marchan
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuei Igarashi
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiko Kashiwagi
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Gernert
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Williams
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen F. Traynelis
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Zheng
National Neuroscience Institute and Department of Pharmacology, National University of Singapore, Singapore (C.-M.L.); Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia (P.L., A.F., P.L., K.Wy., W.H.T., E.M.M., S.F.T., F.Z.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.I., K.K.); BimCore Computing Center, Emory University, Atlanta, Georgia (K.G.); Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (K.Wi.); and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (F.Z.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Extracellular protons inhibit N-methyl-d-aspartate (NMDA) receptors with an IC50 value in the physiological pH range. To identify the molecular determinants of proton sensitivity, we used scanning mutagenesis of the NR1 subunit to search for residues that control proton inhibition of NMDA receptors. Homology modeling of the extracellular domains suggested that residues at which mutations perturbed pH sensitivity were localized in discrete regions. The majority of mutations that strongly affected proton sensitivity were clustered in the extracellular end of the second transmembrane domain (M3) and adjacent linker leading to the S2 portion of the glycine-binding domain of NR1. Mutations in NR2A confirmed that the analogous region controls the pH sensitivity of this subunit and also identified the linker region between the third transmembrane domain (M4) and the S2 portion of the NR2 glutamate binding domain as an additional determinant of proton sensitivity. One mutant receptor, NR1(A649C)/NR2A(A651T), showed a 145-fold reduction in the IC50 for protons (IC50, 17.3 μM corresponding to pH 4.9). The M3-S2 linker region has been suggested to control NMDA receptor gating, leading to the hypothesis that the proton sensor and receptor gate may be structurally and functionally integrated.

  • Received December 24, 2002.
  • Accepted February 26, 2003.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 63 (6)
Molecular Pharmacology
Vol. 63, Issue 6
1 Jun 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Determinants of Proton-Sensitive N-Methyl-d-aspartate Receptor Gating
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherAccelerated Communication

Molecular Determinants of Proton-Sensitive N-Methyl-d-aspartate Receptor Gating

Chian-Ming Low, Polina Lyuboslavsky, Adam French, Phuong Le, Karen Wyatte, William H. Thiel, Edward M. Marchan, Kazuei Igarashi, Keiko Kashiwagi, Kim Gernert, Keith Williams, Stephen F. Traynelis and Fang Zheng
Molecular Pharmacology June 1, 2003, 63 (6) 1212-1222; DOI: https://doi.org/10.1124/mol.63.6.1212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherAccelerated Communication

Molecular Determinants of Proton-Sensitive N-Methyl-d-aspartate Receptor Gating

Chian-Ming Low, Polina Lyuboslavsky, Adam French, Phuong Le, Karen Wyatte, William H. Thiel, Edward M. Marchan, Kazuei Igarashi, Keiko Kashiwagi, Kim Gernert, Keith Williams, Stephen F. Traynelis and Fang Zheng
Molecular Pharmacology June 1, 2003, 63 (6) 1212-1222; DOI: https://doi.org/10.1124/mol.63.6.1212
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAA Receptor Desensitization by Low GABA
  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
Show more Accelerated Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics